WO2020142282A3 - Composition de soins personnels, procédé de préparation de la composition et procédé de traitement impliquant la composition - Google Patents

Composition de soins personnels, procédé de préparation de la composition et procédé de traitement impliquant la composition Download PDF

Info

Publication number
WO2020142282A3
WO2020142282A3 PCT/US2019/068026 US2019068026W WO2020142282A3 WO 2020142282 A3 WO2020142282 A3 WO 2020142282A3 US 2019068026 W US2019068026 W US 2019068026W WO 2020142282 A3 WO2020142282 A3 WO 2020142282A3
Authority
WO
WIPO (PCT)
Prior art keywords
composition
nanoparticles
personal care
preparing
treatment method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2019/068026
Other languages
English (en)
Other versions
WO2020142282A2 (fr
Inventor
James Casey
David Witker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dow Silicones Corp
Original Assignee
Dow Silicones Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Silicones Corp filed Critical Dow Silicones Corp
Publication of WO2020142282A2 publication Critical patent/WO2020142282A2/fr
Publication of WO2020142282A3 publication Critical patent/WO2020142282A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B33/00—Silicon; Compounds thereof
    • C01B33/02—Silicon
    • C01B33/021—Preparation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25—Silicon; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A61Q3/04—Nail coating removers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/413—Nanosized, i.e. having sizes below 100 nm
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/82—Preparation or application process involves sonication or ultrasonication

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)

Abstract

Une composition comprend des nanoparticules. Les nanoparticules sont produites par un procédé au plasma. Les nanoparticules comprennent indépendamment un élément du groupe IV. La composition comprend en outre au moins un composant de soins personnels. Un procédé de préparation de la composition (« procédé de préparation ») consiste à produire des nanoparticules par l'intermédiaire d'un procédé au plasma. Le procédé de préparation comprend en outre l'association des nanoparticules à au moins un composant de soins personnels. Un procédé de traitement d'un substrat (« procédé de traitement ») consiste à appliquer la composition sur le substrat. Le substrat comprend généralement des cheveux, de la peau, des dents et/ou des ongles.
PCT/US2019/068026 2018-12-31 2019-12-20 Composition de soins personnels, procédé de préparation de la composition et procédé de traitement impliquant la composition Ceased WO2020142282A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862786995P 2018-12-31 2018-12-31
US62/786,995 2018-12-31

Publications (2)

Publication Number Publication Date
WO2020142282A2 WO2020142282A2 (fr) 2020-07-09
WO2020142282A3 true WO2020142282A3 (fr) 2020-10-15

Family

ID=69326676

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2019/068026 Ceased WO2020142282A2 (fr) 2018-12-31 2019-12-20 Composition de soins personnels, procédé de préparation de la composition et procédé de traitement impliquant la composition

Country Status (1)

Country Link
WO (1) WO2020142282A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116392403B (zh) * 2023-04-26 2024-12-31 上海皮宝生物科技发展有限公司 一种防晒组合物、水包油防晒乳制剂及其制备方法和应用

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006011014A1 (fr) * 2004-07-16 2006-02-02 L'oreal Composition cosmetique contenant des particules photoluminescentes
US20090056628A1 (en) * 2004-06-18 2009-03-05 Uwe Kortshagen Process and apparatus for forming nanoparticles using radiofrequency plasmas
US20100129300A1 (en) * 2008-11-18 2010-05-27 Nanosi Advanced Technologies, Inc. Organosilicon compounds, fatty acids and oils with homogenous silicon nanoparticle dispersions
WO2011109299A1 (fr) * 2010-03-01 2011-09-09 Dow Corning Corporation Nanoparticules photoluminescentes et procédé de préparation de celles-ci
US20130105806A1 (en) * 2011-11-01 2013-05-02 Guojun Liu Structures incorporating silicon nanoparticle inks, densified silicon materials from nanoparticle silicon deposits and corresponding methods
WO2013184458A1 (fr) * 2012-06-05 2013-12-12 Dow Corning Corporation Capture fluidique de nanoparticules
US20150325328A1 (en) * 2014-04-18 2015-11-12 Regents Of The University Of Minnesota Group iv nanocrystals having a surface substantially free of oxygen
WO2018147684A1 (fr) * 2017-02-10 2018-08-16 주식회사 쇼나노 Composition de matériau barrière aux ultraviolets comprenant des nanoparticules de non-oxyde de groupe carbone et son procédé de production

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352808A (en) 1980-12-12 1982-10-05 Schering Corporation 3-Aralkyloxy-2,3-dihydro-2-(imidazolylmethyl)benzo(b)thiophenes and related derivatives, their use as antimicrobials and pharmaceutical formulations useful therefore
US4985459A (en) 1984-02-08 1991-01-15 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
US6162432A (en) 1991-10-07 2000-12-19 Biogen, Inc. Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction
KR20110056400A (ko) 2008-09-03 2011-05-27 다우 코닝 코포레이션 나노입자들을 제조하기 위한 저압 고주파수 펄스형 플라즈마 리액터
US8258917B2 (en) 2010-03-03 2012-09-04 Measurement Systems, Inc. Intuitive multiple degrees of freedom portable control device

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090056628A1 (en) * 2004-06-18 2009-03-05 Uwe Kortshagen Process and apparatus for forming nanoparticles using radiofrequency plasmas
WO2006011014A1 (fr) * 2004-07-16 2006-02-02 L'oreal Composition cosmetique contenant des particules photoluminescentes
US20100129300A1 (en) * 2008-11-18 2010-05-27 Nanosi Advanced Technologies, Inc. Organosilicon compounds, fatty acids and oils with homogenous silicon nanoparticle dispersions
WO2011109299A1 (fr) * 2010-03-01 2011-09-09 Dow Corning Corporation Nanoparticules photoluminescentes et procédé de préparation de celles-ci
US20130105806A1 (en) * 2011-11-01 2013-05-02 Guojun Liu Structures incorporating silicon nanoparticle inks, densified silicon materials from nanoparticle silicon deposits and corresponding methods
WO2013184458A1 (fr) * 2012-06-05 2013-12-12 Dow Corning Corporation Capture fluidique de nanoparticules
US20150325328A1 (en) * 2014-04-18 2015-11-12 Regents Of The University Of Minnesota Group iv nanocrystals having a surface substantially free of oxygen
WO2018147684A1 (fr) * 2017-02-10 2018-08-16 주식회사 쇼나노 Composition de matériau barrière aux ultraviolets comprenant des nanoparticules de non-oxyde de groupe carbone et son procédé de production

Also Published As

Publication number Publication date
WO2020142282A2 (fr) 2020-07-09

Similar Documents

Publication Publication Date Title
PH12018502634A1 (en) Topical compositions of apremilast
AU2018284960A1 (en) AADC polynucleotides for the treatment of Parkinson's disease
NZ593771A (en) Cyclosporine compositions for enhancing nail growth
MX2011010859A (es) Peptidos utiles en el tratamiento y/o cuidado de la piel y/o cabello y su uso en composiciones cosmeticas o farmaceuticas.
MX2021010058A (es) Formulaciones de rapamicina tópicas y su uso en el tratamiento de angiofibromas faciales y otros trastornos de la piel.
EP4349360A3 (fr) Peptide présentant une activité d'amélioration des rides et ses utilisations
AU2020217620B2 (en) Compounds useful for the treatment and/or care of the skin, hair, nails and/or mucous membranes
MX2016009852A (es) Sistemas para el cuidado de la piel despues del procedimiento, composiciones y metodos de uso de los mismos.
SG11201906787UA (en) Injectable composition for preventing hair loss or stimulating hair growth
MX2015013148A (es) Nuevos compuestos de bencensulfonamida, metodo para sintetizar los mismos, y uso de los mismos en medicina asi como tambien en cosmeticos.
EP4427815A3 (fr) Pirfénidone enrichie en deutérium et ses procédés d'utilisation
PH12019502874A1 (en) Antibacterial activity of galactooligosaccharide and xylitol in dermatological treatments
WO2019103658A3 (fr) Dérivés de 1,4-benzodiazépine et leur utilisation
EP1594885B8 (fr) Medicament pour inhiber la croissance de tumeurs
MX2022004052A (es) Composicion novedosa para el cuidado de la piel.
WO2020142282A3 (fr) Composition de soins personnels, procédé de préparation de la composition et procédé de traitement impliquant la composition
WO2019099860A3 (fr) Traitement de plaie contenant du collagène et un agent de réduction de gélatine, et méthode d'aide à la cicatrisation de plaie
WO2019138291A3 (fr) Compositions pharmaceutiques topiques pour la peau contenant du cerdulatinib et leurs utilisations
MX2021012353A (es) Composicion cosmetica topica y usos de la misma.
WO2018158542A8 (fr) Cellules souches mesenchymateuses issues de la gelée de wharton pour le traitement du sepsis
WO2020117516A8 (fr) Utilisation de composés poly(acide carboxylique) pour le traitement de substrats fibreux à base d'acides aminés, spécialement des cheveux
MX2019005818A (es) Preparacion cosmetica de viscosidad mejorada para tratamiento de fibras queratinicas, metodo para incrementar la viscosidad de una preparacion cosmetica, uso de ingredientes modificadores de la viscosidad y metodo de tratamiento de fibras queratinicas.
MX2022004050A (es) Composicion novedosa para el cuidado de la piel.
MX2022004055A (es) Composicion novedosa para el cuidado de la piel.
EP3884771A4 (fr) Composition pour reconstituer un tissu cutané humain ayant des follicules pileux, modèle animal de tissu cutané humain, et son procédé de production

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19842969

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19842969

Country of ref document: EP

Kind code of ref document: A2